Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8433870 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| SCHEMBL8731747 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| SCHEMBL9634040 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| SCHEMBL4463569 | 1.00 | — | — | |
| SCHEMBL7004366 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| SCHEMBL7192762 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| SCHEMBL5215841 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL9183679 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL8592149 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL9635014 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119133615-B | Preparation method of novel polymer-based efficient lithium ion battery electrolyte | 湖南大晶新材料有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119133615-A | Preparation method of novel polymer-based efficient lithium ion battery electrolyte | 湖南大晶新材料有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-112399852-A | Targeting of multiple antigen receptor T cells to multiple antigens in solid and liquid malignancies | 达纳-法伯癌症研究所有限公司 | 2021-02-23 | — | — | CN | claimed |
| US-12497394-B2 | Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2025-12-16 | — | — | US | disclosed |
| CN-119133615-B | Preparation method of novel polymer-based efficient lithium ion battery electrolyte | 湖南大晶新材料有限公司 | 2025-02-18 | — | — | CN | disclosed |
| WO-2025031471-A1 | NOVEL HETEROCYCLIC COMPOUND FOR REGULATING P53 FUNCTION | 德睿智药(苏州)新药研发有限公司 | 2025-02-13 | — | — | WO | disclosed |
| CN-119133615-A | Preparation method of novel polymer-based efficient lithium ion battery electrolyte | 湖南大晶新材料有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-113767090-B | Tricyclic compound, preparation method and medical application thereof | 中国医药研究开发中心有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-11904030-B2 | Dental composition | DENTSPLY SIRONA INC. (US) | 2024-02-20 | — | — | US | disclosed |
| EP-3518863-B1 | DENTAL COMPOSITION | DENTSPLY DETREY GMBH (DE) | 2023-11-15 | — | — | EP | disclosed |
| CN-115108999-B | Phenyl piperazine quinazoline compound or pharmaceutically acceptable salt thereof, preparation method and application | 暨南大学 | 2023-11-03 | — | — | CN | disclosed |
| US-20160087213-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING FULLERENE DERIVATIVE | LG CHEM, LTD. (KR) | 2016-03-24 | — | — | US | disclosed |
| EP-2975663-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING FULLERENE DERIVATIVE | LG Chem, Ltd. (KR) | 2016-01-20 | — | — | EP | disclosed |
| CN-102282709-B | Process for producing polymeric electrolyte membrane | TORAY INDUSTRIES | 2014-05-14 | — | — | CN | disclosed |
| EP-0746563-A1 | METHOD FOR THE DEPOSITION OF NICKEL AND/OR NICKEL OXIDE FROM THE GAS PHASE, AND NOVEL NICKEL COMPOUNDS HAVING STABLE VAPORISATION CHARACTERISTICS | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 1996-12-11 | — | — | EP | disclosed |
| EP-0434570-B1 | Steroid products carrying a substituted thioethyl group in position 10, a process for their preparation and intermediates of this process, their use as medicines and pharmaceutical preparations containing them | ROUSSEL UCLAF (FR) | 1996-03-27 | — | — | EP | disclosed |
| WO-1995023155-A1 | METHOD FOR THE DEPOSITION OF NICKEL AND/OR NICKEL OXIDE FROM THE GAS PHASE, AND NOVEL NICKEL COMPOUNDS HAVING STABLE VAPORISATION CHARACTERISTICS | NEDERLANDSE ORGANISATIE VOOR TOEGEPASTNATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 1995-08-31 | — | — | WO | disclosed |
| US-5086047-A | Controlling estrogen production; breast cancer | ROUSSEL UCLAF, DEPARTMENT DES BREVETS (FR) | 1992-02-04 | — | — | US | disclosed |
| EP-0434570-A2 | Steroid products carrying a substituted thioethyl group in position 10, a process for their preparation and intermediates of this process, their use as medicines and pharmaceutical preparations containing them | ROUSSEL UCLAF (FR) | 1991-06-26 | — | — | EP | disclosed |
| EP-0225137-A2 | Process for producing a tetraalkoxysilane | Chisso Corporation (JP) | 1987-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11904030-B2 | Dental composition | CBR3, CBR1, PRDX3 | ALDH1A1 2034/4885TSHR 4242/4885 |
| US-12497394-B2 | Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof | AXL, WEE1, FLT3 | ALDH1A1 3585/4885TSHR 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.